EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Homologous Recombination Repair Deficiency: An Overview for Pathologists

Kenneth D Doig, Andrew P Fellowes, Stephen B Fox

Modern Pathology · 2023-03 · 36 (3) · 100049

DOI: 10.1016/j.modpat.2022.100049 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Modern Pathology, 2023-03. Verfasst von Kenneth D Doig und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Mel…. Hauptthemen laut MEDLINE: Recombinational DNA Repair, Ovarian Neoplasms. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The repair of DNA double-stranded breaks relies on the homologous recombination repair pathway and is critical to cell function. However, this pathway can be lost in some cancers such as breast, ovarian, endometrial, pancreatic, and prostate cancers. Cancer cells with homologous recombination deficiency (HRD) are sensitive to targeted inhibition of poly-ADP ribose polymerase (PARP), a key component of alternative backup DNA repair pathways. Identifying patients with cancer with HRD biomarkers allows the identification of patients likely to benefit from PARP inhibitor therapies. In this study, we describe the causes of HRD, the underlying molecular changes resulting from HRD that form the basis of different molecular HRD assays, and discuss the issues around their clinical use. This overview is directed toward practicing pathologists wishing to be informed of this new predictive biomarker, as PARP inhibitors are increasingly used in standard care settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Recombinational DNA RepairOvarian NeoplasmsFemaleHumansHomologous RecombinationPathologistsDNA Repair

Stichwörter der Autor:innen

HRDPARPiclinical sequencinghomologous recombination deficiencyhomologous recombination repairmolecular diagnostics

Autor:innen und Institutionen

  • Department of Pathology, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: Ken.Doig@p…
  • Department of Pathology, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.
  • Department of Pathology, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

Zitieren

APA

Doig, K. D., Fellowes, A. P., & Fox, S. B. (2023). Homologous Recombination Repair Deficiency: An Overview for Pathologists. Modern Pathology, 36(3), 100049. https://doi.org/10.1016/j.modpat.2022.100049

Vancouver

Doig KD, Fellowes AP, Fox SB. Homologous Recombination Repair Deficiency: An Overview for Pathologists. Modern Pathology. 2023;36(3):100049. doi:10.1016/j.modpat.2022.100049

BibTeX
@article{Doig2023,
  author = {Doig, Kenneth D and Fellowes, Andrew P and Fox, Stephen B},
  title = {Homologous Recombination Repair Deficiency: An Overview for Pathologists},
  journal = {Modern Pathology},
  year = {2023},
  volume = {36},
  number = {3},
  pages = {100049},
  doi = {10.1016/j.modpat.2022.100049}
}
Kostenlos starten →